Asahi Kasei Corporation, Siemens Healthcare GmbH and Medtronic are Dominating the China Hospitals and Pharmacy Market in 2020

China Hospitals and Pharmacy Market is expected to grow with the CAGR of 12.0% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

China hospitals & pharmacy market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in China hospitals & pharmacy market are introducing strong range of medicines provider along with launching new medicines and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In November 2016, China Traditional Chinese Medicine Holdings Co. Limited acquired the Shanghai Tongjitang Guizhou Tongjitang Decoction Pieces. This initiative helped the company to boost up its product portfolio of traditional Chinese medicines and to earn more revenue by enhancing product sales.

Asahi Kasei Corporation is the dominating player in China hospitals and pharmacy market. The other key players existing in the market includes Takazono Corporation, TOSHO co., Inc., YUYAMA Co.,Ltd, Shanghai Qiyou Precision Electromechanical Co., Ltd., Shandong New Beiyang Information Technology Co., Ltd., Jiangsu Hanyoung Automation Tech Co., Ltd. HollySys Asia Pacific Pte Ltd., Asahi Kasei Medical Co., Ltd. (A subsidiary of Asahi Kasei Corporation), Intuitive Surgical, Medtronic, Stryker, Omnicell, Inc., BD, Baxter, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare and Johnson & Johnson Services, Inc. among others.

China Hospitals and Pharmacy Market

Asahi Kasei Corporation

Asahi Kasei Corporation headquartered in Tokyo and it was established in year 1931. The Company is engaged in the development, manufacturing and commercialization of medical devices and related products. The company is focused on material sector, homes sector, and health care sector in which health care sector is the market focused segment. The company has wide product portfolio including pharmaceuticals, medical care, acute critical care in which acute critical care are the market focused products.

  • In August 2019, ZOLL Medical Corporation (US), a subsidiary of Asahi Kasei Corporation, completed the acquisition of Cardiac Science Corporation which is a manufacturer of automated external defibrillators. The acquisition has further enhanced the already well established position of ZOLL Medical Corporation and strengthened the portfolio with the help of product line-up from Cardiac Science Corporation. This has propelled the growth of the market in recent years.

The company has presence across North America, Europe, Asia-Pacific. The company has various subsidiaries which Asahi Kasei (China) Co. Ltd. (China), Asahi Kasei America Inc. (New York), Asahi Kasei Advance Corporation (Japan), Asahi Kasei E-Materials Korea Inc. (South Korea), Asahi Kasei Emd Taiwan Corporation (Taiwan) among others.

Siemens Healthcare GmbH

Siemens Healthcare GmbH headquartered in Guangzhou, China and it was established in year 1896. The company operates as a holding company and intends to operate the digital services business. The company is focused on Imaging, Diagnostics and Advanced Therapies in which Imaging is the market focused segment. The company has wide product portfolio including CT Computer Tomography Scanner, Magnetic Resonance Imaging, Angiography Equipment , Molecular Imaging, Radiotherapy Imaging, Medical IT Solutions, X-Ray Photography, Mammography, Ultrasound Scanning System, Mobile C-Arm X-Ray Machine and Urinary Solution, Laboratory Diagnosis, Point-of-Care Diagnosis, Customer Services in which Laboratory Diagnosis, Medical Imaging are the market focused products.

For instance

  • In December 2020, Siemens Healthcare GmbH has developed a new innovation with the expertise in machine vision, they are improving in automation. The company and team is applying artificial intelligence and deep learning for depth studies on how to reduce the failure rate of automation in vitro diagnostics. From this new innovation the company will engage with more consumers by providing them help and thereby increase in market value.

The company has presence in North America, Europe, Asia-Pacific, South America, Middle East and Africa. The company has various subsidiaries such as Siemens Healthcare Diagnostics S.A.E. (Egypt), Siemens Healthcare Morocco), Siemens Healthcare K.K. (Japan), Siemens Healthineers Beteiligungen Gmbh & Co. Kg (Germany), Siemens Healthineers Ltd.(South Korea) among others.


Medtronic is headquartered in Dublin, Ireland and it was established in year 1949. The company is engaged in offering medical technologies through services and solutions. The company deals in the Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, Diabetes Group in which Minimally Invasive Therapies Group is the market focused segment. The company is engaged in providing wide range of products such as Patients & Caregivers, Healthcare Professionals in which Healthcare Professionals is market focused product.

For instance,

  • In June 2019, Medtronic announced its partnership with KARL STORZ SE & Co. KG, a leader in field of endoscopy imaging in order to bring advanced robotic assisted surgical platform. This partnership done by Medtronic will increase its product portfolio in future leading to increased demands for its product in the market.

The company is present in North America, Europe, Asia-Pacific, South America, Middle East and Africa. The company has various subsidiaries such as 2074417 Alberta ULC  (Canada), A&E Hangers Taiwan Co., Ltd. (Taiwan), A&E Products (Far East) Limited (Hong Kong), A&E Products de Honduras S.A. (Honduras),  A&E Products do Brasil Ltda. (Brazil) among others.